Raymond James Maintains Outperform Rating for NOV: Here's …

Oct 30, 2023 · Raymond James has decided to maintain its Outperform rating of NOV (NYSE:NOV) and raise its price target from $28.00 to $29.00. Shares of NOV are trading down …

$28.00
OFF

Raymond James Maintains Outperform Rating For NOV: Here's …

2 weeks from now

Oct 30, 2023 · Raymond James has decided to maintain its Outperform rating of NOV (NYSE:NOV) and raise its price target from $28.00 to $29.00. Shares of NOV are trading down …

businessinsider.com

64%
OFF

Raymond James Maintains NOV (NOV) Outperform …

2 weeks from now

Jul 6, 2023 · Fintel reports that on July 14, 2023, Raymond James maintained coverage of NOV with a Outperform recommendation. Analyst Price Forecast Suggests 37.64% Upside As of …

nasdaq.com

$25
OFF

NOV Inc.: Target Price Consensus And Analysts Recommendations …

2 weeks from now

1 day ago · NOV Inc. analysts consensus, targets, ratings and recommendations | Nyse: NOV | Nyse ... Raymond James Adjusts Price Target on NOV to $25 From $28, Maintains …

marketscreener.com

$20
OFF

Raymond James Adjusts Price Target On Huntington Bancshares To …

2 weeks from now

Jan 8, 2025 · RBC Capital Adjusts Price Target on Huntington Bancshares to $20 From $17, Maintains Outperform Rating Nov. 11: MT Huntington Bancshares Incorporated Presents at …

marketscreener.com

$84
OFF

Raymond James Downgrades Fidelity National Information …

2 weeks from now

Jan 6, 2025 · BNP Paribas Exane Adjusts PT on Fidelity National Information Services to $84 From $80, Maintains Neutral Rating Nov. 05: MT Morgan Stanley Adjusts PT on Fidelity …

marketscreener.com

$117
OFF

Stock Upgrades And Downgrades - MarketsBlock

2 weeks from now

Nov 20, 2024 · Baird initiates coverage on ServiceTitan at Outperform rating and announces a price target of $117. Raymond James maintains Masimo MASI at Outperform and raises the …

marketsblock.com

657%
OFF

Amentum Soars Following Raymond James' Outperform Rating

2 weeks from now

Nov 21, 2024 · The upgrade by Raymond James' analyst Brian Gesuale boosts Amentum's stock by 8.657%. ... Amentum Soars Following Raymond James' Outperform Rating. ShantiPutri . …

yahoo.com

15%
OFF

How To Read Our Equity Research Reports - Raymond James

2 weeks from now

How to Read Our Equity Research Reports Raymond James & Associates (U.S.) definitions. Strong Buy (SB1) Expected to appreciate, produce a total return of at least 15%, and …

raymondjames.com

$32.00
OFF

Deep Dive Into Weyerhaeuser Stock: Analyst Perspectives (4 Ratings)

2 weeks from now

1 day ago · Raymond James: Announces: Outperform: $32.00-Ketan Mamtora: BMO Capital: Maintains: Outperform: $38.00: $38.00: Key Insights: Action Taken: ... Rating: Analysts unravel qualitative evaluations for ...

benzinga.com

$19.00
OFF

Raymond James Maintains Outperform Rating For Host Hotels

2 weeks from now

Mar 15, 2024 · Raymond James has decided to maintain its Outperform rating of Host Hotels & Resorts (NASDAQ:HST) and raise its price target from $19.00 to $23.00.

businessinsider.com

$95.00
OFF

Fortinet's (FTNT) "Market Perform" Rating Reaffirmed At Raymond …

2 weeks from now

1 day ago · Robert W. Baird lifted their price objective on shares of Fortinet from $95.00 to $100.00 and gave the company an "outperform" rating in a report on Tuesday, November …

marketbeat.com

$298.00
OFF

What 15 Analyst Ratings Have To Say About Alnylam …

2 weeks from now

2 days ago · Raymond James: Raises: Outperform: $298.00: $275.00: Luca Issi: RBC Capital: Maintains: Outperform: $300.00: $300.00 ... from 'Outperform' to 'Underperform'. These …

nasdaq.com

$25
OFF

5 Analysts Assess Flywire: What You Need To Know | Nasdaq

2 weeks from now

1 day ago · In the assessment of 12-month price targets, analysts unveil insights for Flywire, presenting an average target of $25.2, a high estimate of $27.00, and a low estimate of $21.00.

nasdaq.com

$25.12
OFF

Where Amerant Bancorp Stands With Analysts | Nasdaq

2 weeks from now

Oct 2, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Amerant Bancorp, presenting an average target of $25.12, a high estimate of $26.50, and a low …

nasdaq.com

$76.00
OFF

Raymond James Maintains Outperform Rating For Micron Technology: Here's ...

2 weeks from now

Nov. 29, 2023, 12:00 PM Raymond James has decided to maintain its Outperform rating of Micron Technology (NASDAQ:MU) and raise its price target from $76.00 to $82.00.

businessinsider.com

$581.95
OFF

Forecasting The Future: 20 Analyst Projections For Mastercard

2 weeks from now

1 day ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $581.95, along with a high estimate of $654.00 and a low …

nasdaq.com

FAQs about Raymond James Maintains Outperform Rating for NOV: Here's … Coupon?

Will Raymond James (Nov) increase its price target?

Raymond James has decided to maintain its Outperform rating of NOV (NYSE:NOV) and raise its price target from $28.00 to $29.00. Shares of NOV are trading down 0.08% over the last 24 hours, at $19.59 per share. A move to $29.00 would account for a 48.07% increase from the current share price. ...

What is Raymond James' Price target?

Raymond James upgrades Block from Market Perform to Outperform and announces a price target of $115 Jefferies upgrades Las Vegas Sands LVS from Hold to Buy and raises the price target from $60 to $69 Jefferies upgrades Boyd Gaming BYD from Hold to Buy and raises the price target from $73 to $92 ...

Does Jefferies buy Royal Gold rgld?

Jefferies upgrades Royal Gold RGLD from Hold to Buy and raises the price target from $154 to $178 Morgan Stanley maintains BP at Equal-Weight and lowers the price target from $34.7 to $31.8 Morgan Stanley upgrades Shell from Equal-Weight to Overweight and raises the price target from $66.5 to $79.8 ...

Is Raymond James A buy on inflarx NV (ifrx)?

Raymond James remains a Strong Buy on Inflarx NV (NASDAQ: IFRX) following 1Q22 earnings based on a promising outlook for vilobelimab in Pyoderma Gangrenosum (PG) and potentially other indications. The biotech macro backdrop has forced many companies to be prudent with cash runway and prioritize clinical programs. ...

Does Jefferies downgrade Masco Mas?

Jefferies downgrades Summit Materials from Buy to Hold and lowers the price target from $58 to $52.5 Needham reiterates Clear Secure YOU at Buy and maintains a price target of $45 Jefferies downgrades Masco MAS from Buy to Hold and lowers the price target from $96 to $89 ...

Does JP Morgan downgrade Xometry?

JP Morgan downgrades Getty Images Holdings from Neutral to Underweight JP Morgan upgrades Xometry from Neutral to Overweight and raises the price target from $25 to $45 Jefferies initiates coverage on Rocket Pharmaceuticals RCKT at Buy rating and announces a price target of $29 ...